Table 6.
Analytes | Cmax (ng/mL) | Tmax (h) | t1/2 (h) | AUC(0-t) (µg/L·h) | AUC(0-∞) (µg/L·h) | MRT(0-t) (h) |
---|---|---|---|---|---|---|
CPS | 119.15 ± 11.25 | 1.00 ± 0.36 | 0.51 ± 0.04 | 143.52 ± 15.73 | 143.52 ± 15.73 | 1.72 ± 0.19 |
RNG | 111.64 ± 14.68 | 3.00 ± 0.25 | 1.33 ± 0.55 | 381.73 ± 24.13 | 387.21 ± 28.06 | 4.28 ± 0.55 |
RNC | 1122.18 ± 113.32 | 5.33 ± 0.63 | 4.15 ± 0.49 | 6540.14 ± 433.70 | 6627.61 ± 471.83 | 4.99 ± 0.11 |
CPS: complanatuside; RNG: rhamnocitrin 3-O-β-glc; RNC: rhamnocitrin; Cmax: the maximum plasma concentration; Tmax: the time to reach the maximum drug concentration; t1/2: half-life; AUC: the area under the plasma concentration-time curve; MRT: the mean residence time.